Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference5 articles.
1. Jakobsen JC , Nielsen EE , Feinberg J , et al . Direct-acting antivirals for chronic hepatitis C. Cochrane Database Syst Rev 2017;6.doi:10.1002/14651858.CD012143.pub2
2. Sofosbuvir-based regimens for chronic hepatitis C in a well-insured U.S. population: patient characteristics, treatment adherence, effectiveness, and health care costs, 2013–2015;Yin;J Manag Care Spec Pharm,2019
3. The impact of treatment of hepatitis C with DAAs on the occurrence of HCC;Roche;Liver Int,2018
4. Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist;Nappi;Infect Agent Cancer,2017
5. Adverse drug reactions: definitions, diagnosis, and management
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献